Subscribe to Newsletter
Subspecialties Pediatric, Basic & Translational Research, Imaging & Diagnostics

Revolutionizing Infant Eye Care

Although artificial intelligence (AI) has been a growing ophthalmic tool over the last couple of years, it has yet to scratch the surface on its pediatric implementation – until now. A group of vision scientists from University College London and Moorfields Eye Hospital have been working on the development of an AI mechanism to detect retinopathy of prematurity (ROP) in infants. The deep learning model aims to 
identify infants at risk of ROP, potentially solving disparities in vision care accessibility.

ROP is a leading cause of blindness during childhood, and although it is readily identifiable at an early stage by pediatric ophthalmologists, it causes a larger problem in areas with few vision care experts. The new AI model works independently of eye care professional availability. Therefore, its potential use in low resource vision care settings is significant. By employing artificial intelligence as an early detection system, doctors can benefit from a greater impact per visiting patient, leaving the burden of screening to other healthcare workers.

The study, published in The Lancet in April 2023, is led by Konstantinos Balaskas, Director of Moorfields Eye Hospital’s Clinical AI Lab and Ophthalmic Reading Center, and Associate Professor at the University College of London’s Institute of Ophthalmology. The AI model was fed with internally and externally assessed retinal images from American, British, Egyptian, and Brazilian data sets, and graded by ophthalmologists based on severity.

After using the developed AI model to assess a dataset of 6141 diverse retinal images, the researchers found that the deep learning mechanism had a significantly similar identification success rate to senior ophthalmologists. Although the study does highlight limitations in the adaptability of the model, especially considering the proven difference in ROP based on ethnic and socio-economic status, it does serve as a major revelation in the employment of AI and deep learning to bridge the gap in treating life-harming sight impairment in infants.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. S Wagner et.al., “Development and international validation of custom-engineered and code-free deep-learning models for detection of plus disease in retinopathy of prematurity: a retrospective study,” The Lancet, [Online ahead of print] (2023). PMID: 37088692.
About the Author
Karim Barake

Trustee Scholar at Boston University and Research Intern at Schepens Eye Research Institute

 

Related Case Study
Business & Profession Glaucoma
TrabEx Pro: The Next Level in MIGS

| Contributed by MST

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: